Scientifically-altered T cells, which produce the body’s immune response, may be a key to defeating leukemia, lymphoma, and multiple myeloma, say authors of a new study.
T cells are white blood cells that permanently patrol human tissues and blood vessels, hunting down foreign invaders such as bacteria and viruses.
These cytotoxic or killer cells can be taken from the cancer patient’s blood and then fortified with added artificial, chimeric antigen receptors as a last-ditch treatment for the above cancers.
